More measles vaccines secured

Extra doses of the MMR vaccine have been secured for NZ.

An extra 35,000 doses of the measles vaccine has been secured for New Zealand as the Government plans a year-long measles-catch-up campaign.

Associate Minister of Health Julie Anne Genter says the Government is investing $40 million into the campaign and $23 million to fully fund and develop the National Immunisation Solution.

“We are making it as easy as possible for young people, Māori and Pasifika people especially, to get vaccinated. Now, immunisation is available in a variety of places, such as schools, workplaces, pharmacies and marae."

Since January 1, 2019, New Zealand has had 2194 cases of measles.

There has been no measles cases in New Zealand since January 24, 2020.

“COVID-19 has disrupted immunisation programmes around the world, increasing the risk of severe outbreaks once travel resumes.

“That’s why we’re doing a catch-up campaign focused on the roughly 300,000 young adults aged between 15 and 30 who are not immune to measles, as their immunisation rate is generally too low to prevent a measles outbreak.

“DHBs know their communities well and how best to target the extra vaccines. They’ll start rolling out their measles campaigns shortly, followed by a national campaign later this year."

Julie Anne says the National Immunisation Register was first set up in 2005 and no longer fit for purpose.

“That’s why this Government has invested $23 million to fully fund and develop the National Immunisation Solution - in efforts to ensure we better monitor who is and isn’t getting measles immunisations, and when a COVID-19 vaccine is developed, we are ready to roll out a mass vaccination programme.

“Let’s protect those around us. Immunisation is the best way to protect and prevent future outbreaks. I encourage whānau with children and people aged 15-30 who may not have been vaccinated to contact their GP to book an appointment. If you're over the age of 15 you can also get the vaccine at some pharmacies."

Subscribe to our daily Newsletter

Email:


You may also like...

0 Comments

There are no comments on this article.

Leave a Comment

You must be logged in to make a comment. Login Now